Key result
ADA and EASD outline updated consensus recommendations for precision medicine in diabetes care.
Answers are grounded in this paper and cite their sources.
THE 59th Annual Meeting of the European Association for the Study of Diabetes (EASD) took place in Hamburg, Germany, as well as virtually. With exciting new developments in diabetes treatment in the forefront of our minds, as described by the EASD President, Chantal Mathieu, presenter Paul Franks from Lund University, Sweden, took to the stage to deliver ‘ADA/EASD Precision Medicine in Diabetes Initiative: Executive Summary of the Second Consensus Report’. Franks provided the key updates to the consensus, published on 5th October 2023, only hours before the presentation.
No takes yet. Share an insight, caveat, or question.
Natasha Meunier-McVey (2023) conducted a review in Diabetes. Precision Medicine was evaluated. The ADA/EASD Precision Medicine in Diabetes Initiative Executive Summary of the Second Consensus Report was presented to outline key updates in precision medicine for diabetes treatment.
Synapse has enriched 5 related papers. Consider them for comparative context: